Bioinformatics Window on Evolution


By Kevin Davies Bio-IT World

An international team including researchers from the National Human Genome Research Institute (NHGRI) has discovered that mammalian chromosomes have evolved over tens of millions of years by breaking at specific sites rather than randomly, as had been widely thought.

Writing in last week’s Science, the researchers compared the genomic architecture of eight mammals: human, mouse, rat, cow, pig, dog, cat and horse. Bioinformatics analysis revealed that during evolution, the chromosomes are rearranged by breaking typically in specific locations, rather than in a random fashion, as had been widely thought. “This study shows the tremendous power of using multi-species genome comparisons to understand evolutionary processes, including those with potential relevance to human disease,” comments Eric Green, NHGRI Scientific Director.

Inherited chromosomal translocations play a key role in evolution by rearranging genetic material, which in rare cases can be beneficial. They can also be deleterious – translocations are often associated with cancer. The researchers find that the chromosome breaks linked to cancer are more likely to occur in proximity to the evolutionary breakage hotspots. The authors also conclude, based on computer-generated reconstructions of the genomes of long-extinct mammals, that there was a sharp increase in the rate of chromosomal evolution among mammals following the demise of the dinosaurs some 65 million years ago.

Authors include Harris Lewin (University of Illinois at Urbana-Champaign) and William J. Murphy, Ph.D., of Texas A&M University in College Station. Other study participants were from the National Cancer Institute, the Genome Institute of Singapore and the University of California at San Diego.

Murphy, W.J. et al. “Dynamics of mammalian chromosome evolution inferred from multispecies comparative maps.” Science 309, 613-617 (2005).

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.





For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.